45 related articles for article (PubMed ID: 28841209)
1. Monoclonal B-cell lymphocytosis in donors.
Stetler-Stevenson M
Blood; 2014 Feb; 123(9):1281-2. PubMed ID: 24578489
[TBL] [Abstract][Full Text] [Related]
2. Cancer Evolution Constrained by the Immune Microenvironment.
McGranahan N; Swanton C
Cell; 2017 Aug; 170(5):825-827. PubMed ID: 28841415
[TBL] [Abstract][Full Text] [Related]
3. B-cell lymphocytosis in relatives of Colombian patients with chronic B-cell lymphoproliferative disorders.
Celis M; Navarro Y; Serrano N; Martínez D; Nieto W
Biomedica; 2023 Dec; 43(Sp. 3):66-78. PubMed ID: 38207149
[TBL] [Abstract][Full Text] [Related]
4. The Cytogenetic Profile of Primary and Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with Differential Circulating Clonal Plasma Cells.
Papadhimitriou SI; Terpos E; Liapis K; Pavlidis D; Marinakis T; Kastritis E; Dimopoulos MA; Tsitsilonis OE; Kostopoulos IV
Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203419
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal B cell lymphocytosis and "in situ" lymphoma.
Karube K; Scarfò L; Campo E; Ghia P
Semin Cancer Biol; 2014 Feb; 24():3-14. PubMed ID: 23999128
[TBL] [Abstract][Full Text] [Related]
6. [Monoclonal B-cell lymphocytosis: physiological entity or preliminary stage of chronic lymphocytic leukaemia?].
Schindhelm RK; van Marwijk Kooy MR; Coenen JL; Huijgens PC; Kuiper-Kramer PA
Ned Tijdschr Geneeskd; 2010; 154():A1520. PubMed ID: 20482911
[TBL] [Abstract][Full Text] [Related]
7. Clonal evolution is a prognostic factor for the clinical progression of monoclonal B-cell lymphocytosis.
Kostopoulos IV; Paterakis G; Pavlidis D; Kastritis E; Terpos E; Tsitsilonis OE; Papadhimitriou SI
Blood Cancer J; 2017 Aug; 7(8):e597. PubMed ID: 28841209
[No Abstract] [Full Text] [Related]
8. Low-count monoclonal B-cell lymphocytosis persists after seven years of follow up and is associated with a poorer outcome.
Criado I; Rodríguez-Caballero A; Gutiérrez ML; Pedreira CE; Alcoceba M; Nieto W; Teodosio C; Bárcena P; Romero A; Fernández-Navarro P; González M; Almeida J; Orfao A;
Haematologica; 2018 Jul; 103(7):1198-1208. PubMed ID: 29567775
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of prognostic factors in asymptomatic patients with B-cell chronic lymphocytic leukemia-like lymphocytosis: the cut-off of 11 × 10(9)/L monoclonal lymphocytes better identifies subgroups with different outcomes.
Oliveira AC; Fernández de Sevilla A; Domingo A; De La Banda E; Domingo-Domènech E; Mercadal S; Ruiz-Xivillé N; Alonso E; Encuentra M; González-Barca E
Ann Hematol; 2015 Apr; 94(4):627-32. PubMed ID: 25471173
[TBL] [Abstract][Full Text] [Related]
10. Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis.
Molica S; Giannarelli D; Levato L; Gentile M; Mirabelli R; Morabito F
Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):e55-60. PubMed ID: 25445470
[TBL] [Abstract][Full Text] [Related]
11. Hospital population screening reveals overrepresentation of CD5(-) monoclonal B-cell lymphocytosis and monoclonal gammopathy of undetermined significance of IgM type.
Voigtlaender M; Vogler B; Trepel M; Panse J; Jung R; Bokemeyer C; Bacher U; Binder M
Ann Hematol; 2015 Sep; 94(9):1559-65. PubMed ID: 26040471
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis.
Parikh SA; Chaffee KG; Larson MC; Hampel PJ; Call TG; Ding W; Kenderian SS; Leis JF; Chanan-Khan AA; Conte MJ; Bowen D; Schwager SM; Slager SL; Hanson CA; Kay NE; Shanafelt TD
Haematologica; 2018 Jun; 103(6):e237-e240. PubMed ID: 29419435
[No Abstract] [Full Text] [Related]
13. Immunophenotypic analysis reveals heterogeneity and common biologic aspects in monoclonal B-cell lymphocytosis.
Kostopoulos IV; Paterakis G; Papadimitriou K; Pavlidis D; Tsitsilonis OE; Papadhimitriou SI
Genes Chromosomes Cancer; 2015 Apr; 54(4):210-21. PubMed ID: 25533355
[TBL] [Abstract][Full Text] [Related]
14. The microenvironment in lymphomas--dissecting the complex crosstalk between tumor cells and 'by-stander' cells.
Rosenquist R; Davi F; Ghia P
Semin Cancer Biol; 2014 Feb; 24():1-2. PubMed ID: 24365642
[TBL] [Abstract][Full Text] [Related]
15. General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL.
Fazi C; Scarfò L; Pecciarini L; Cottini F; Dagklis A; Janus A; Talarico A; Scielzo C; Sala C; Toniolo D; Caligaris-Cappio F; Ghia P
Blood; 2011 Dec; 118(25):6618-25. PubMed ID: 21876118
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
